Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bionano Genomics Inc BNGO

Technology Scientific & Technical Instruments
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform... see more

Recent & Breaking News (NDAQ:BNGO)

Bionano Genomics Emphasizes the Importance of Supporting the Proxy Proposal to Increase its Authorized Shares

GlobeNewswire August 28, 2020

Bionano Genomics Appoints Tech Executive Christopher Stewart as its Chief Financial Officer to Help Manage, Grow and Expand Bionano's Global Business

GlobeNewswire August 26, 2020

Bionano Genomics Acquires Diagnostics Services Provider Lineagen, Inc. to Accelerate Clinical Adoption of Saphyr for Digital Cytogenetics

GlobeNewswire August 24, 2020

Bionano Saphyr Services Offered in CLIA Certified Lab Expands Bionano Genomics' Clinical Applications

GlobeNewswire August 20, 2020

Bionano Genomics Appoints Industry Leading Cytogeneticist Dr. Alka Chaubey as the Company's First Chief Medical Officer to Help Lead the Conversion of Cytogenetics to Digital Cytogenetics with Saphyr

GlobeNewswire August 18, 2020

Bionano Genomics Announces "At-The-Market" Equity Program

GlobeNewswire August 17, 2020

Bionano Genomics Reports Second Quarter 2020 Financial Results and Provides Business Update

GlobeNewswire August 13, 2020

Bionano Featured at Cancer Genomics Consortium Annual Meeting with Multiple Data Readouts that Further Validate Saphyr in the Field of Cytogenetics and Lay Groundwork for a Novel LDT in Cancer

GlobeNewswire August 10, 2020

Bionano Genomics to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 13

GlobeNewswire August 7, 2020

Studies on COVID-19 Disease Susceptibility in China Using Bionano Genomics' Saphyr Are Progressing and Generating High Quality Data

GlobeNewswire August 6, 2020

Metastatic Lung Cancer Study Finds That Bionano's Saphyr Outperforms NGS for the Detection of Structural Variants

GlobeNewswire August 3, 2020

Bionano Genome Imaging Provides Essential Scaffolding Results in High Profile Bat Genome Study

GlobeNewswire July 29, 2020

The COVID-19 Host Genome Structural Variant Consortium Formed by Dr. Ravindra Kolhe at Augusta University Creates a Massive Expansion in the Scope of COVID-19 Susceptibility Research with Bionano Genome Imaging

GlobeNewswire July 24, 2020

Bionano Genome Imaging Identifies the Most Common Structural Variations Between Individuals with DiGeorge Syndrome

GlobeNewswire July 23, 2020

First Publication from International Consortium Using Bionano Imaging in Genetic Disease Patients Demonstrates that Bionano's Saphyr Detects All 100 Chromosomal Aberrations in 85 Samples

GlobeNewswire July 20, 2020

Bionano Genomics Data is Essential Part of the First Ever Complete Assembly of a Human X-Chromosome

GlobeNewswire July 16, 2020

Bionano Genomics Solidifies its Entry into Solid Tumor Analysis with Launch of New Kit and Protocol that Significantly Simplify Tissue and Solid Tumor Analysis

GlobeNewswire July 9, 2020

First Extensive Validation Study of Saphyr for Constitutional Genetic Disorders by European Consortium Shows 100% Concordance to Standard Cytogenetics and Describes Resolution of Cases of Long-Standing, Undiagnosed Disease

GlobeNewswire July 8, 2020

The UK NHS, the Medical College of Wisconsin, and the Leading South Korean Yonsei University Hospital are Among Newest Adopters of Bionano Saphyr® for Digital Cytogenetic Applications

GlobeNewswire June 26, 2020

Bionano Genomics Reports First Quarter 2020 Financial Results and Provides Business Update

GlobeNewswire June 18, 2020